| Antibody-based capture of 2019-nCoV and its inactivation using lipid-based in situ gel | Dr. Kiran Kondabagil, Associate Professor, Indian Institute of Technology (IIT), Mumbai | 2020 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | COVID-19 Research, Life Sciences & Biotechnology, Pharmaceutical Sciences |
| Dr-COVID: Graph Neural Networks for SARS-CoV-2 Drug Repurposing | Dr Sundeep Prabhakar Chepuri, Assistant Professor, Indian Institute of Science (IISc), Bengaluru | 2020 | | Life Sciences & Biotechnology, Pharmaceutical Sciences, Computer Sciences and Information Technology, COVID-19 Research |
| Preclinical Efficacy Validation In Non-Human Primate Stroke Model Of Anti-Thrombin-Clot Specific Streptokinase (ACSSK), With Dual Properties Of Fibrin Specific Clot Dissolution And Prevention Of Arterial Re-Occlusion, For The Treatment Of Acute Myocardial Infarction And Ischemic Stroke | Dr Yogendra Padwad, Scientist, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Life Sciences & Biotechnology, Medical Sciences, Pharmaceutical Sciences |
| Computational prediction of possible nCoV-19 structural proteins inhibitors from Azadirachta indica (Neem) Five potential compounds screened for CL-3 protease protein of nCov19 | Prof Manidipa Banerjee, Indian Institute of Technology (IIT) Delhi | 2020 | | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences |
| Engineering of epitope peptides from structural and non-structural proteins of coronavirus 2019-nCoV on Virus-Like particle (VLPs) to develop vaccine candidates | Dr Rajkumara, Assistant Professor, Indian Institute of Technology (IIT) Hyderabad | 2020 | | Life Sciences & Biotechnology, COVID-19 Research, Pharmaceutical Sciences, Chemical Sciences |
| Target identification and hit-to-lead optimization of SRI-12742 targeting MDR A baumannii | Dr Sidharth Chopra, Scientist, Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Life Sciences & Biotechnology, Medical Sciences, Pharmaceutical Sciences |
| Determination of biofilm pharmacodynamics of newly formulated, nano-conjugated antibiotics to optimize treatment and dosing of chronic, antibiotic-resistant biofilm infections | Dr Gopal Chandra Kundu, Scientist & Director, National Centre for Cell Science (NCCS), Maharashtra | 2019 | Indian Council of Medical Research (ICMR), New Delhi - German Federal Ministry of Education and Research (BMBF), Germany | Life Sciences & Biotechnology, Medical Sciences, Pharmaceutical Sciences |
| Development of Monitoring and Evaluation protocol for accelerated MDA (Mass Drug Administration) with IDA (Ivermectin, Diethylcarbamazine and Albendazole) for lymphatic filariasis elimination programme | Dr Jambulingam P, Director, Vector Control Research Centre (ICMR-VCRC), Puducherry | 2019 | Bill & Melinda Gates Foundation (BMGF),
USA | Pharmaceutical Sciences, Life Sciences & Biotechnology, Medical Sciences, Mathematical Sciences |
| Healthcare Technology Innovation Centre (HTIC)-Phase II | Dr. Mohanasankar Sivaprakasam, Associate Professor, Indian Institute of Technology (IIT), Chennai | 2018 | Department of Biotechnology (DBT), Government of Inida | Life Sciences & Biotechnology, Pharmaceutical Sciences |
| Development of PD-1/PDL-1 check point inhibitor(s) for adjuvant therapy | Dr. C Gopi Mohan, Associate Professor, Amrita Vishwa Vidyapeetham Amritapuri Campus (AVVAC), Kollam | 2018 | Department of Biotechnology (DBT), Government of India, New Delhi | Life Sciences & Biotechnology, Pharmaceutical Sciences |